CLINICAL TRIALS PROFILE FOR TEDIZOLID PHOSPHATE
✉ Email this page to a colleague
All Clinical Trials for TEDIZOLID PHOSPHATE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01170221 ↗ | TR-701 FA vs. Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections. | Completed | Trius Therapeutics LLC | Phase 3 | 2010-08-15 | This is a randomized, double-blind, double dummy, multicenter Phase 3 study of oral TR-701 FA 200 mg once daily for 6 days versus oral Zyvox® (linezolid) 600 mg every 12 hours for 10 days for the treatment of ABSSSI in adults. Approximately 75 to 100 sites globally will participate in this study. Patients with an ABSSSI caused by suspected or documented gram positive pathogen(s) at baseline will be randomized 1:1 to study treatment |
NCT01539473 ↗ | A Phase 1 TR-701 FA Study of Blood Pressure Response Post Tyramine Challenge | Completed | Trius Therapeutics LLC | Phase 1 | 2012-02-01 | Phase 1 study to determine the effect of oral TR-701 FA on SBP response when administered with tyramine |
NCT01577459 ↗ | A Phase 1 Crossover Study of Blood Pressure and Heart Rate Response | Completed | Trius Therapeutics LLC | Phase 1 | 2012-04-23 | This is a randomized, double-blinded, placebo-controlled, crossover study to evaluate the pressor effects of pseudoephedrine when administered with TR-701 FA in healthy adult volunteers. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TEDIZOLID PHOSPHATE
Condition Name
Clinical Trial Locations for TEDIZOLID PHOSPHATE
Trials by Country
Clinical Trial Progress for TEDIZOLID PHOSPHATE
Clinical Trial Phase
Clinical Trial Sponsors for TEDIZOLID PHOSPHATE
Sponsor Name